Corrigendum to “Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiota” [J. Pharm. Biomed. Anal. 248 (2024) 116325]
Xianfeng Zhang(Beth Israel Deaconess Medical Center), Yan Wang(National Institute of Biological Sciences, Beijing), Zhao Zhai(Chinese Academy of Medical Sciences & Peking Union Medical College), Xinyu Yang(Gansu Academy of Agricultural Sciences), Hang Yu(Humboldt-Universität zu Berlin), Hengtong Zuo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Yue Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mengliang Ye(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Tong(Jilin University), Jian‐Ye Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingyue Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Xu(City University of Macau), Haojian Zhang(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine), Jie Fu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiachun Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Xiang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
|Signal Transduction and Targeted Therapy|2021|315
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
|Acta Pharmaceutica Sinica B|2019|217
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
|Signal Transduction and Targeted Therapy|2022|186